MYOLEX, INC.

Davie, FL · Medtech · Private

Wearable electrical impedance myography (EIM) device for non-invasive acute compartment syndrome detection

myolex.com →
Grants
$11M
16 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$31K
2 awards · Health and Human S
#595 of 4531 in medtech
Patents
5
3 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of Health and Human Services · Convergence Medical DEVICES:1186957 [13-004280]$27,000
Federal grantDepartment of Health and Human Services · Phase II · A device for rapid, painless, bedside muscle evaluation of children with neuromus$754,696
Federal contractDepartment of Health and Human Services · Medical And Surgical Instruments, Equipment, And Supplies$3,750
Federal grantDepartment of Health and Human Services · Phase I · Optimizing electrical impedance myography outcomes through data mining$149,998
Federal grantDepartment of Health and Human Services · Phase II · Electrical impedance myography technology for quantitative, at-home muscle assessment in amyotrophic lateral sclerosis and other neuromuscular disorders.$862,065
Federal grantDepartment of Health and Human Services · Phase I · Innovative Electrode Designs for Next Generation Electrical Impedance Myography$225,000
Federal grantDepartment of Health and Human Services · Phase I · Technology for the non-invasive surveilance of post-traumatic compartment syndrome$225,000
Federal grantDepartment of Health and Human Services · Phase II · An integrated electrical impedance myography platform for neuromuscular disease classification and diagnosis$621,318
Federal grantDepartment of Health and Human Services · Phase II · Electrical impedance myography technology for quantitative, at-home muscle assessment in amyotrophic lateral sclerosis and other neuromuscular disorders.$632,777
Federal grantDepartment of Health and Human Services · Phase II · An integrated electrical impedance myography platform for neuromuscular disease classification and diagnosis$869,698
Federal grantDepartment of Health and Human Services · Phase II · Early identification and prevention of acute compartment syndrome using a novel electrical impedance-based muscle-monitoring device$1,677,772
Federal grantDepartment of Health and Human Services · Phase II · Accurate and rapid assessment of sarcopenia in older adults through electrical impedance myography$889,385
Federal grantDepartment of Health and Human Services · Phase II · Early identification and prevention of acute compartment syndrome using a novel electrical impedance-based muscle-monitoring device$979,965
Federal grantDepartment of Health and Human Services · Phase II · Accurate and rapid assessment of sarcopenia in older adults through electrical impedance myography - Development of Regulatory Plans Supplement$50,000
Federal grantDepartment of Health and Human Services · Phase II · Accurate and rapid assessment of sarcopenia in older adults through electrical impedance myography$813,035
Federal grantDepartment of Health and Human Services · Phase II · Convenient quantification of myopathic change in muscle via electrical impedance myography$1,006,120
Federal grantDepartment of Health and Human Services · Phase II · Convenient quantification of myopathic change in muscle via electrical impedance myography$963,608
Federal grantDepartment of Health and Human Services · Phase I · Electrical impedance myography (EIM) to detect and track cancer cachexia$263,052
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
592Atlas Spine, Inc.$33K$3.5M
593LIGHTSENSE TECHNOLOGY INC$32K$20K
594INTEGRATED VIRAL PROTECTION SOLUTIONS LLC$32K—
595MYOLEX, INC.$31K—
596CIONIC, Inc.$30K$35M
597Eight Sleep Inc.$30K$149M
598NeuroMetrix, Inc.$29K$19M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 3 granted of 5

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.